APLENZIN: payments to doctors
Payments that named APLENZIN as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.2M
- Providers
- 13,992
- Transactions
- 67,074
- Average per transaction
- $18
The per-transaction average — $18 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 13,992 providers the average total is $87, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Bausch Health US, LLC | $1,209,807 | 99.9% |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | $1,599 | 0.1% |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | $58 | 0.0% |